Markus Obermüller Selected Research

Markus Obermüller Research Topics

2	Peritonitis 01/2020 - 01/2019
1	Legionellosis 01/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021
1	Sepsis (Septicemia) 12/2017
1	Infections 12/2017

2	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2019
1	FluoroquinolonesIBA 01/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	MacrolidesIBA 01/2021
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Vitamin D FDA LinkGeneric 12/2017
1	hydroxide ionIBA 12/2017
1	ProcalcitoninIBA 12/2017

2	Peritoneal Dialysis 01/2020 - 01/2019
1	Therapeutics 01/2019